PDF
Abstract
Coffee, a popular drink around the world, is composed of a complex mix of biologically active molecules, including caffeine, chlorogenic acid, and diterpenes. These compounds have antioxidant, anti-inflammatory, antifibrotic, and anticarcinogenic properties, which may explain observational data showing that coffee drinkers have lower rates of chronic liver disease, including cirrhosis and hepatocellular carcinoma (HCC). Recent studies have also shown that coffee consumption may also increase patient survival before and after liver transplantation. The mechanism by which coffee consumption protects against HCC is not clear; however, its relevant role has been demonstrated. This literature review article focuses on the role of coffee consumption in protecting against the development of HCC. Methodology: Scientific articles indexed through PubMed, including Medline, Scielo, and Lilacs, published in English were used as search methods. The terms used in English were: “hepatocellular carcinoma” or “Liver cancer” or “HCC” and “coffee”. According to the study design or review article, cross-sectional, longitudinal, or descriptive investigations were included, showing site and year of publication until 2019.
Keywords
Hepatocellular carcinoma
/
coffee consumption protection
/
liver cancer
Cite this article
Download citation ▾
Kellyane S. D. Carvalho, Helma P. Cotrim.
Coffee protection against the development of hepatocellular carcinoma: review article.
Hepatoma Research, 2020, 6: 6 DOI:10.20517/2394-5079.2019.027
| [1] |
Bosetti C,Malvezzi M,Chatenoud L.Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980..Ann Oncol2013;24:2657-71
|
| [2] |
Chuang SC,Boffetta P.Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection..Cancer Lett2009;286:9-14
|
| [3] |
Trichopoulos D,Lagiou P,Trepo E.Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested casecontrol study..J Natl Cancer Inst2011;103:1686-95 PMCID:PMC3216968
|
| [4] |
Barros RK,Daltro C,de Freitas LRA.Nonalcoholic steatohepatitis in morbid obese patients: coffee consumption vs. disease severity..Ann Hepatol2016;15:350-5
|
| [5] |
Wierzejska R.Coffee consumption vs. cancer risk - a review of scientific data..Rocz Panstw Zakl Hig2015;66:293-8
|
| [6] |
Yu X,Zou J.Coffee consumption and risk of cancers: a meta-analysis of cohort studies..BMC Cancer2011;11:96 PMCID:PMC3066123
|
| [7] |
Ruhl CE.Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States..Gastroenterology2005;128:24-32
|
| [8] |
Bohn SK,Paur I.Coffee and cancer risk, epidemiological evidence, and molecular mechanisms..Mol Nutr Food Res2014;58:915-30
|
| [9] |
Hösel M,Wiegmann K,Zedler U.Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection..Hepatology2009;50:1773-82
|
| [10] |
Takaki A.Control of oxidative stress in hepatocellular carcinoma: helpful or harmful?.World J Hepatol2015;7:968 PMCID:PMC4419100
|
| [11] |
Murphy MP.How mitochondria produce reactive oxygen species..Biochem J2008;417:1-13 PMCID:PMC2605959
|
| [12] |
Degli Esposti D,Bosselut N,Sebagh M.Mitochondrial roles and cytoprotection in chronic liver injury..Biochem Res Int2012;2012:387626 PMCID:PMC3382253
|
| [13] |
Pedro JMB,Filigheddu N,Porporato PE.Mitochondrial metabolism and cancer..Cell Res2017;28:265-80 PMCID:PMC5835768
|
| [14] |
Dhanasekaran R,Roberts LR.Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances..F1000Res2016;5:879 PMCID:PMC4870992
|
| [15] |
Okano J,Matsumoto K.Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/EGFR signalling pathway..Basic Clin Pharmacol Toxicol2008;102:543-51
|
| [16] |
Cavin C,Scharf G,Schilter B.Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity..Food Chem Toxicol2002;40:1155-63
|
| [17] |
Huber WW,Rossmanith W,Grasl-Kraupp B.The coffee components kahweol and cafestol induce gamma-glutamylcysteine synthetase, the rate limiting enzyme of chemoprotective glutathione synthesis, in several organs of the rat..Arch Toxicol2002;75:685-94
|
| [18] |
Tanaka K,Sakamoto T,Mizuta T.Inverse association between coffee drinking and the risk of hepatocellular carcinoma: a case-control study in Japan..Cancer Sci2007;98:214-8
|
| [19] |
Hu G,Pukkala E,Antikainen R.Joint effects of coffee consumption and serum gamma-glutamyltransferase on the risk of liver cancer..Hepatology2008;48:129-36
|
| [20] |
Cano-Marquina A,Cano A.The impact of coffee on health..Maturitas2013;75:7-21
|
| [21] |
Inoue M,Sobue T.Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan..J Natl Cancer Inst2005;97:293-300
|
| [22] |
Johnson S.Coffee consumption and reduced risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study..Cancer Causes Control2012;22:503-10 PMCID:PMC3400401
|
| [23] |
Bamia C,Jenab M,Fedirko V.Coffee, tea and decaffeinated coffee in relation to hepatocellular carcinoma in a European population: multicentre, prospective cohort study..Int J Cancer2015;136:1899-908 PMCID:PMC6284785
|
| [24] |
Aleksandrova K,Drogan D,Trichopoulou A.The association of coffee intake with liver cancer risk is mediated by biomarkers of inflammation and hepatocellular injury: data from the European Prospective Investigation into Cancer and Nutrition..Am J Clin Nutr2015;102:1498-508 PMCID:PMC4658462
|
| [25] |
Kurozawa Y,Shibata A,Yoshimura T.Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan..Br J Cancer2005;93:607-10 PMCID:PMC2361599
|
| [26] |
Kondili LA,Gunson B,Olliff S.Primary hepatocellular cancer in the explanted liver: outcome of transplantation and risk factors for HCC recurrence..Eur J Surg Oncol2007;33:868-73
|
| [27] |
Eini H,Yulzari R,Lewis EC.Caffeine promotes anti-tumor immune response during tumor initiation: involvement of the adenosine A2A receptor..Biochem Pharmacol2015;98:110-8
|